Smith & Nephew PLC

SN.: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|$@gLOCK|V%>hnLOCK|YK@n%$Q

Smith & Nephew Earnings: Sports Medicine Strength Offsets Knee Softness

Smith & Nephew saw abbreviated first-quarter results that included underlying revenue growth of 3%, with strong growth in sports medicine/joint repair (up 10%) and arthroscopic-enabling technologies (up 7%).

Sponsor Center